Analyzing the Estrogen Receptor Status of Liver Metastases with [<sup>18</sup>F]-FES-PET in Patients with Breast Cancer

Analyzing the Estrogen Receptor Status of Liver Metastases with [<sup>18</sup>F]-FES-PET in Patients with Breast Cancer

Background: Positron emission tomography (PET) with 16α-[<sup>18</sup>F]-fluoro-17β-estradiol ([<sup>18</sup>F]-FES) can visualize estrogen receptor (ER) expression, but it is challenging to determine the ER status of liver metastases, due to high physiological [<sup>18...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Jorianne Boers, Naila Loudini, Robbert J. de Haas, Antoon T. M. Willemsen, Bert van der Vegt, Elisabeth G. E. de Vries, Geke A. P. Hospers, Carolina P. Schröder, Andor W. J. M. Glaudemans, Erik F. J. de Vries
Format: article
Langue:EN
Publié: MDPI AG 2021
Sujets:
FES-PET/CT
breast cancer
liver metastases
estrogen receptor
quantification
Medicine (General)
R5-920
Accès en ligne:https://doaj.org/article/55c90a5881014d0d86ff8c95e773378a
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/55c90a5881014d0d86ff8c95e773378a

Documents similaires